[go: up one dir, main page]

MA25696A1 - L'effet medical de l'huile de jojoba - Google Patents

L'effet medical de l'huile de jojoba

Info

Publication number
MA25696A1
MA25696A1 MA26720A MA26720A MA25696A1 MA 25696 A1 MA25696 A1 MA 25696A1 MA 26720 A MA26720 A MA 26720A MA 26720 A MA26720 A MA 26720A MA 25696 A1 MA25696 A1 MA 25696A1
Authority
MA
Morocco
Prior art keywords
jojoba oil
medical effect
medical
effect
jojoba
Prior art date
Application number
MA26720A
Other languages
English (en)
Inventor
Sadek El Mogy Nabil
Original Assignee
South Egypt Drug Ind Co Sedico
Egyptian Natural Oil Co Natoil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South Egypt Drug Ind Co Sedico, Egyptian Natural Oil Co Natoil filed Critical South Egypt Drug Ind Co Sedico
Publication of MA25696A1 publication Critical patent/MA25696A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/004—Preparations used to protect coloured hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0288—Applications, solvents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
MA26720A 2001-07-07 2002-07-04 L'effet medical de l'huile de jojoba MA25696A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG20010750 2001-07-07

Publications (1)

Publication Number Publication Date
MA25696A1 true MA25696A1 (fr) 2003-04-01

Family

ID=8163780

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26720A MA25696A1 (fr) 2001-07-07 2002-07-04 L'effet medical de l'huile de jojoba

Country Status (6)

Country Link
US (4) US6846499B2 (fr)
EP (1) EP1281401A3 (fr)
JP (1) JP2003063978A (fr)
CN (1) CN1275606C (fr)
MA (1) MA25696A1 (fr)
TN (1) TNSN02063A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138134B2 (en) * 2001-12-18 2006-11-21 Arizona Health Consulting Group, Llc Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
AU2003248831A1 (en) * 2002-07-08 2004-01-23 Isca Technologies Method of producing vertebrate host mimic with modified lipid based media
US7025957B2 (en) * 2002-09-06 2006-04-11 Desert Whale Jojoba Company Composition and method to whiten skin
WO2004023979A2 (fr) * 2002-09-12 2004-03-25 Biosyn, Inc. Formulation de mucus pour surfaces de muqueuses et utilisations associees
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
FR2856304B1 (fr) * 2003-06-20 2006-03-03 Natural Product Consulting Composition pour la prevention des infections du systeme urinaire
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
CA2559503A1 (fr) * 2004-03-12 2006-01-12 Melbj Holdings, Llc Lubrifiant pour la surface oculaire
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
JP5038331B2 (ja) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー 銅と亜鉛の組成物を用いた老化防止治療
JP2007238488A (ja) * 2006-03-07 2007-09-20 Kose Corp 乳化型皮膚外用剤
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
EP2124868A4 (fr) * 2007-03-29 2014-06-11 Int Flora Technologies Ltd Traitement des symptômes de dermatose touchant un tégument mammalien avec des formulations désinfectantes émollientes
JP4891207B2 (ja) * 2007-11-27 2012-03-07 大洋香料株式会社 抗菌剤及びそれを含有する皮膚外用剤
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
FR2940125B1 (fr) 2008-12-23 2013-03-22 Isp Investments Inc Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
FR2940291B1 (fr) 2008-12-23 2012-12-21 Isp Investments Inc Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
WO2010085753A1 (fr) 2009-01-23 2010-07-29 Jr Chem, Llc Traitements pour l'acné rosacée et trousses médicales pour les mettre en pratique
FR2944446B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944445B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2944526B1 (fr) 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
MX2012010823A (es) 2010-03-26 2012-10-10 Galderma Res & Dev Metodos y composiciones mejoradas para tratamiento seguro y efectivo de telangiectasia.
BR112012024289A2 (pt) 2010-03-26 2017-07-18 Galderma Res & Dev "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica"
AR076729A1 (es) 2010-06-01 2011-07-06 Univ Nac De Cordoba Procedimiento para la obtencion de una dispersion acuosa de alcoholes y acidos a partir de aceite de jojoba, procedimientos para la obtencion de aceite de jojoba autoemulsionado, dispersiones acuosas y emulsiones de aceite de jojoba en las mismas y composiciones farmaceuticas o cosmeticas que las co
EP2629757A2 (fr) 2010-10-21 2013-08-28 Galderma S.A. Compositions de gel de brimonidine et leurs procédés d'utilisation
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
CN103648378B (zh) 2011-05-12 2016-10-12 橄榄医疗公司 用于使用竖直互连的混合堆叠图像传感器的子列并行数字转换器的系统和方法
ES2871250T3 (es) * 2011-11-30 2021-10-28 Frutarom Ltd Extracto de jojoba útil para mejorar las funciones de barrera cutánea
ITRM20120174A1 (it) * 2012-04-23 2013-10-24 Aboca Spa Societa Agricola Nuove composizioni per il trattamento delle ferite croniche.
MX346174B (es) 2012-07-26 2017-03-10 Depuy Synthes Products Inc Esquema de iluminacion pulsada ycbcr en un entorno deficiente de luz.
IN2015MN00019A (fr) 2012-07-26 2015-10-16 Olive Medical Corp
IN2015MN00018A (fr) 2012-07-26 2015-10-16 Olive Medical Corp
AU2013359392C1 (en) 2012-12-12 2016-12-08 Orbis Health Solutions, Llc Compositions and methods for tissue regeneration
US10251530B2 (en) 2013-03-15 2019-04-09 DePuy Synthes Products, Inc. Scope sensing in a light controlled environment
EP2967286B1 (fr) 2013-03-15 2021-06-23 DePuy Synthes Products, Inc. Minimisation du nombre d'entrée/de sortie et de conducteur d'un capteur d'image dans des applications endoscopes
EP2967285B1 (fr) 2013-03-15 2023-08-16 DePuy Synthes Products, Inc. Synchronisation de capteur d'image sans signal d'horloge d'entrée et signal d'horloge de transmission de données
EP3459431A1 (fr) 2013-03-15 2019-03-27 DePuy Synthes Products, Inc. Commande de l'énergie lumineuse intégrale d'une impulsion laser
JP2016519591A (ja) 2013-03-15 2016-07-07 オリーブ・メディカル・コーポレイションＯｌｉｖｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ パルスカラー撮像システムにおける超解像度及び色運動アーチファクト補正
CN114191114A (zh) 2014-03-21 2022-03-18 德普伊新特斯产品公司 用于成像传感器的卡缘连接器
US20190298626A1 (en) * 2016-12-16 2019-10-03 Aak Ab (Publ) Petrolatum substitution preparation
WO2021013315A1 (fr) * 2019-07-22 2021-01-28 Mostafa Mariam Mohamed Kamel Onguent pour traitement d'ulcère du pied diabétique
CN116869899A (zh) * 2023-08-16 2023-10-13 青岛威巴克生物技术有限公司 一种护肤除菌免洗凝露及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4381296A (en) * 1980-06-23 1983-04-26 Tinnell James E Treatment for herpes virus
US4591602A (en) * 1982-04-16 1986-05-27 James H. Brown Ozonide esters and topical compositions containing same
JPS59225111A (ja) * 1983-06-07 1984-12-18 Kao Corp 肛門周辺部の清浄・清拭剤組成物
JPS59227815A (ja) * 1983-06-08 1984-12-21 Kao Corp 皮膚清浄・清拭剤組成物
US4759798A (en) * 1983-10-19 1988-07-26 Nostitz F Von Process for the preparation of dental-technical, dental-medical and medical molding and lining materials
US4585656A (en) * 1984-08-20 1986-04-29 Rosenthal Harold R Treatment of herpes
DE3811081A1 (de) * 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
DE3836971C1 (fr) * 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De
JPH0816051B2 (ja) * 1988-12-07 1996-02-21 エスエス製薬株式会社 徐放性坐剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
WO1993010756A1 (fr) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Emploi d'acide salicylique contre les rides et/ou l'atrophie cutanee
US5516923A (en) * 1992-04-27 1996-05-14 Agritech International Extracting oil from oil bearing plant parts
EP0648114B1 (fr) * 1992-07-08 1997-09-17 DIANORM G. Maierhofer GmbH Liposomes, procede concernant leur fabrication, et leur utilisation dans la fabrication d'un medicament
JP3496967B2 (ja) * 1993-12-28 2004-02-16 御木本製薬株式会社 抗プラスミン剤
FR2714831B1 (fr) * 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
JPH0892027A (ja) * 1994-09-20 1996-04-09 Shiseido Co Ltd にきび用固形粉末外用剤
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
US20010014316A1 (en) * 1999-02-11 2001-08-16 Marie Harbeck Liquid cleansing composition
US20010005509A1 (en) * 1999-02-11 2001-06-28 Marie Harbeck Foot cream composition
US20010001666A1 (en) * 1999-02-11 2001-05-24 Marie Harbeck Liquid skin treatment
US6558710B1 (en) * 1999-06-14 2003-05-06 Helen Rebecca Godfrey Topical zinc compositions and methods of use
DE19939836A1 (de) * 1999-08-21 2001-02-22 Beiersdorf Ag Wasserhaltige kosmetische oder pharmazeutische Stifte
US20010046526A1 (en) * 2000-04-19 2001-11-29 C-Quest Treatment of fungal infections
US6582736B2 (en) * 2001-03-23 2003-06-24 Terra De Sol Therapeutic oil composition
US20020187165A1 (en) * 2001-05-15 2002-12-12 Joseph F. Long Composition for female sexual arousal
US6893648B2 (en) * 2002-01-04 2005-05-17 Harold Mermelstein Composition and method for treatment of vaginal dryness
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin

Also Published As

Publication number Publication date
EP1281401A3 (fr) 2003-06-25
EP1281401A2 (fr) 2003-02-05
TNSN02063A1 (en) 2005-12-23
US20040170711A1 (en) 2004-09-02
US6846499B2 (en) 2005-01-25
US20040170710A1 (en) 2004-09-02
US20040170712A1 (en) 2004-09-02
US20030008022A1 (en) 2003-01-09
JP2003063978A (ja) 2003-03-05
CN1395964A (zh) 2003-02-12
CN1275606C (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
MA25696A1 (fr) L'effet medical de l'huile de jojoba
FR20C1039I2 (fr) Derives de l'uk-2a
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
EP1428866A4 (fr) Composition d'huile lubrifiante
EP1516910A4 (fr) Composition d'huile de graissage
DE60215179D1 (de) Dolastatin 10 derivate
FR2799502B1 (fr) Deflecteur d'huile
EP1561799A4 (fr) Composition d'huile lubrifiante
EP1526170A4 (fr) Composition d'huile lubrifiante
EP1184446A4 (fr) Composition de refroidissement d'huile mouvement
EP1485452A4 (fr) Compositions d'huile en circulation
FI20001656A0 (fi) Potilaan sähköisten ominaisuksien seuraaminen
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
FR2821545B1 (fr) Ensemble prothetique pour l'articulation de l'epaule
EP1279721A4 (fr) Compositions d'huile de graissage
EP1526169A4 (fr) Composition d'huile lubrifiante
TR199900189A3 (tr) Zeytin yaginin aciliginin giderilmesi
MA25714A1 (fr) Agent d'amendement et agent pour la dynamisation de l'eau.
FR2832922B1 (fr) Prothese d'epaule
ITMI20011833A0 (it) Agenti che regolano la permeabilita' vascolare
FR2808690B3 (fr) Formulation medicale pour la dissipation de contractures musculaires
ITMI20000810A0 (it) Procedimento per la preparazione di 5'-acetilstavudina
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
IT1304791B1 (it) Procedimento per l'abbattimento di microparticelle contenute innebbie oleose.